Zevra Therapeutics, Inc. (ZVRA) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for your continued patience. Your meeting will begin shortly. If you need assistance at any time, please press star zero, and a member of our team will be happy to help you. ¦ ¦ ¦ ¶¶ ¦ ¦ ¦ Thank you for your continued patience. Your meeting will begin shortly. ¦ ¦ ¦ ¶¶ ¶¶ ¶¶ Thank you for your continued patience your meeting will begin shortly. ¶¶ Thank you. Thank you for your continued patience. Your meeting will begin shortly. ¶¶ ¶¶ Good afternoon, and thank you for joining Zevra's third quarter 2025 financial results and corporate update conference call. Today's call is being recorded and will be available via the Investor Relations section of the company's website later today. The host for today's call is Nicole Osher, Zevra's Vice President of Investor Relations and Corporate Communications. Please go ahead. Thank you, and welcome to those who are joining us. Today, we will provide an overview of our recent accomplishments, followed by a review of our third quarter financial results. I encourage you to read our financial results news release, which was distributed this afternoon and is available in the investor section of our website. Before we begin the call, please note that certain information shared today will include forward-looking statements. Actual results may differ materially from those stated or implied in any forward-looking statements due to risks and uncertainties associated with Zephyr's business. Forward-looking statements are not promises or guarantees and are inherently subject to risks, uncertainties, and other important factors that may lead to actual results differing materially from the projections made and should be evaluated together with the risk factor section in our most recent quarterly report on Form 10-Q, our annual report...